StatSeal vs Figure-of-Eight Suture for Vascular Closure in AF Ablation
1 other identifier
interventional
160
1 country
3
Brief Summary
This study, titled aims to compare two vascular closure techniques after catheter ablation for atrial fibrillation (AF). Catheter ablation is a common procedure used to treat AF, but after the procedure, It is important to close the access site in the blood vessel to prevent bleeding. This study will evaluate whether the StatSeal device, a haemostatic disc, can help patients recover more quickly compared to the traditional figure-of-eight suture technique. The primary objective of the study is to determine whether StatSeal reduces the time it takes for patients to start walking after the procedure (known as Time to Ambulation). Secondary objectives include comparing the time to complete haemostasis, discharge eligibility, incidence of adverse events, and patient comfort between the two techniques. Participants in the study will be randomly assigned to receive either the StatSeal device or the figure-of-eight suture after their AF ablation procedure. The study will recruit 160 participants across multiple hospital sites, with 80 participants in each group. Both techniques are standard methods, and participants will be closely monitored for safety throughout the study. By comparing these two closure techniques, the study aims to improve the recovery process for patients undergoing AF ablation and provide evidence on which method leads to better outcomes and patient experiences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2025
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2024
CompletedFirst Posted
Study publicly available on registry
October 4, 2024
CompletedStudy Start
First participant enrolled
January 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedDecember 23, 2025
January 1, 2025
11 months
October 1, 2024
December 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to ambulation (TTA) after sheath removal
Time to ambulation is defined as the elapsed time between removal of the final sheath and the moment when the patient can stand and walk 20 feet without evidence of venous re-bleeding from the femoral access site.
1 day
Secondary Outcomes (7)
Time to haemostasis
1 day
Time to discharge eligibility
1 day
Time to discharge
1 day
Incidence of major periprocedural adverse events
1 day
Incidence of major adverse events
30 days
- +2 more secondary outcomes
Study Arms (2)
Statseal
ACTIVE COMPARATORThis group shall receive the StatSeal device for vascular closure
Figure of eight suture
ACTIVE COMPARATORThis group shall receive the figure of eight suture (attached to a three-way stopcock) for vascular closure
Interventions
This is a vascular closure device which works independently of the clotting cascade to seal access sites
The figure of eight suture is commonly used for vascular access closure
Eligibility Criteria
You may qualify if:
- Male and female patients age \>18
- Elective catheter ablation for atrial fibrillation using a 6 to 14 Fr inner diameter introducer sheath with a minimum of 1 and maximum of 3 femoral venous access sites
- Willing and able to give informed consent
You may not qualify if:
- Active systemic or cutaneous infection, or inflammation in vicinity of the groin
- Platelet count \< 100,000 cells/mm3
- BMI \> 45 kg/m2 or \< 20 kg/m2
- Attempted femoral arterial access or inadvertent arterial puncture
- Procedural complications that interfered with routine recovery, ambulation, or discharge times
- Incorrect sheath placement
- Intraprocedural bleeding or thrombotic complications
- Access site-specific eligibility criteria to exclude problems with gaining access or location of sheath
- History of bleeding diathesis, coagulopathy, hypercoagulability, or thromboembolic events
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
The Essex Cardiothoracic Centre
Basildon, Essex, SS16 5NL, United Kingdom
East Sussex Healthcare NHS Trust
Eastbourne, BN21 2UD, United Kingdom
Norfolk and Norwich University Hospital
Norwich, NR4 7UY, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2024
First Posted
October 4, 2024
Study Start
January 3, 2025
Primary Completion
December 12, 2025
Study Completion
January 1, 2026
Last Updated
December 23, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share